Mechanism of Action of Mirtazapine

Introduction

Mirtazapine is an atypical antidepressant classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). It is commonly used in major depressive disorder, particularly in patients with insomnia, weight loss, or anxiety. Unlike SSRIs and TCAs, mirtazapine enhances neurotransmitter release by blocking inhibitory receptors rather than inhibiting reuptake.


Mechanism of Action (Step-wise)

  1. Mirtazapine blocks presynaptic α2-adrenergic autoreceptors.
  2. These receptors normally inhibit norepinephrine (NE) release.
  3. Blocking α2 autoreceptors increases norepinephrine release.
  4. It also blocks α2 heteroreceptors on serotonergic neurons.
  5. This increases serotonin (5-HT) release.
  6. Mirtazapine selectively antagonizes 5-HT2 and 5-HT3 receptors.
  7. This shifts serotonin activity toward 5-HT1 receptors, enhancing antidepressant effects.
  8. Blocking 5-HT2 reduces anxiety, insomnia, and sexual dysfunction.
  9. Blocking 5-HT3 reduces nausea and gastrointestinal side effects.
  10. Mirtazapine also blocks H1 histamine receptors.
  11. This contributes to sedation and increased appetite.
  12. The net effect is increased noradrenergic and serotonergic neurotransmission with improved tolerability.

A key exam point is that mirtazapine increases NE and serotonin release via α2 blockade and selectively blocks 5-HT2 and 5-HT3 receptors.

Flowchart of mechanism of action of Mirtazapine
Mechanism of Action of Mirtazapine Flowchart

Pharmacokinetics

Mirtazapine is administered orally and is well absorbed. It has moderate bioavailability and reaches peak plasma levels within a few hours. It is metabolized in the liver via cytochrome P450 enzymes (CYP1A2, CYP2D6, CYP3A4). It has a relatively long half-life, allowing once-daily dosing, usually at night due to its sedative effects. It is excreted via urine and feces.


Clinical Uses

Mirtazapine is used in major depressive disorder, especially in patients with insomnia, anxiety, or poor appetite. It is also useful in elderly patients due to its sedative and appetite-stimulating properties. It may be used in cases where SSRIs are not tolerated or cause significant side effects such as sexual dysfunction.


Adverse Effects

Common adverse effects include sedation, weight gain, and increased appetite due to H1 receptor blockade. Dry mouth and dizziness may also occur. Unlike SSRIs, it has a lower risk of sexual dysfunction. Rare but serious adverse effects include agranulocytosis. Because of sedation, it is typically given at bedtime.


Comparative Analysis

FeatureMirtazapineSSRIsTCAs
Mechanismα2 blockade + 5-HT2/3 antagonismSerotonin reuptake inhibitionNE and serotonin reuptake inhibition
SedationHighLowModerate
Weight gainCommonRareModerate
Sexual dysfunctionLowHighModerate
Anticholinergic effectsMinimalMinimalHigh
UseDepression with insomniaFirst-line depressionAlternative

Mirtazapine differs from SSRIs by increasing neurotransmitter release rather than blocking reuptake and has lower risk of sexual dysfunction. Compared to TCAs, it has fewer anticholinergic effects but more sedation and weight gain.


MCQs

  1. Mirtazapine belongs to which class?
    a) SSRI
    b) TCA
    c) NaSSA
    d) MAOI

Answer: c) NaSSA

  1. Mirtazapine blocks which receptor to increase NE release?
    a) β1 receptor
    b) α2 receptor
    c) Dopamine receptor
    d) H2 receptor

Answer: b) α2 receptor

  1. Blocking α2 receptors leads to:
    a) Decreased NE
    b) Increased NE
    c) No change
    d) Increased dopamine

Answer: b) Increased NE

  1. Mirtazapine also increases:
    a) Dopamine
    b) Serotonin
    c) Acetylcholine
    d) GABA

Answer: b) Serotonin

  1. Mirtazapine blocks which serotonin receptors?
    a) 5-HT1
    b) 5-HT2 and 5-HT3
    c) 5-HT4
    d) 5-HT5

Answer: b) 5-HT2 and 5-HT3

  1. Blocking 5-HT3 reduces:
    a) Anxiety
    b) Nausea
    c) Sleep
    d) Appetite

Answer: b) Nausea

  1. Sedation is due to blockade of:
    a) Dopamine receptors
    b) H1 receptors
    c) α1 receptors
    d) β receptors

Answer: b) H1 receptors

  1. Mirtazapine is used in:
    a) Asthma
    b) Depression
    c) Diabetes
    d) Hypertension

Answer: b) Depression

  1. A common adverse effect is:
    a) Weight loss
    b) Weight gain
    c) Hypoglycemia
    d) Bradycardia

Answer: b) Weight gain

  1. Compared to SSRIs, mirtazapine causes:
    a) More sexual dysfunction
    b) Less sexual dysfunction
    c) Same effect
    d) No effect

Answer: b) Less sexual dysfunction

  1. Mirtazapine is metabolized in the:
    a) Kidney
    b) Liver
    c) Lung
    d) Brain

Answer: b) Liver

  1. Mirtazapine is usually given at:
    a) Morning
    b) Noon
    c) Night
    d) Afternoon

Answer: c) Night


FAQs

What is the mechanism of action of mirtazapine?
It blocks α2 receptors to increase norepinephrine and serotonin release and antagonizes 5-HT2 and 5-HT3 receptors.

Why does mirtazapine cause sedation?
Due to H1 histamine receptor blockade.

Does mirtazapine cause sexual dysfunction?
It has a lower risk compared to SSRIs.

Why is mirtazapine useful in insomnia?
Because of its sedative effects.

What is a major metabolic side effect?
Weight gain and increased appetite.

How does mirtazapine differ from SSRIs?
It increases neurotransmitter release instead of inhibiting reuptake.


References

Goodman & Gilman’s The Pharmacological Basis of Therapeutics – Antidepressants
https://accessmedicine.mhmedical.com/book.aspx?bookid=3191

Katzung: Basic and Clinical Pharmacology – Antidepressants
https://accessmedicine.mhmedical.com/content.aspx?bookid=3382

Tripathi: Essentials of Medical Pharmacology – Antidepressants
https://www.jaypeedigital.com

Harrison’s Principles of Internal Medicine – Depression
https://accessmedicine.mhmedical.com

Author

  • Harsh Singh Author Pharmacy Freak

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators